Este mes de Agosto, la reunión del Grupo de Parkinson en Español de la Universidad de Stanford, se realizará de forma conjunta con la Biblioteca de Salud de Stanford. La Dra. Carla Abdelnour explicará en qué consisten los ensayos clínicos, y cómo nos ayudan a desarrollar medicamentos de forma segura y eficaz.
… Full Story>
A great way to help your neurologist better understand your symptoms is to keep close track of what you’re experiencing and when. The American Parkinson Disease Association (APDA) developed the free APDA Symptom Tracker mobile app to do just that.
… Full Story>
This month the Stanford Parkinson’s Community Outreach Program hosted a lunch for former PD caregivers who attended our support groups. Those in attendance had lost their loved one from one week to four years ago.
We asked them to share their thoughts on a few questions to benefit current PD caregivers. Here are the questions we asked our lunch attendees and their wise advice:
The recent FDA approvals for donanemab (Kinsunla®) and lecanemab (Leqembi®) for the treatment of Alzheimer’s mark a major step forward for dementia research. While these treatments focus on Alzheimer’s, they offer hope for Parkinson’s disease as well.
… Full Story>
The American Parkinson Disease Association (APDA) is proud to partner with Smart Patients, an online community for people with Parkinson’s disease (PD) and their care partners. On July 16-18, Smart Patients is hosting a special 3-day Ask the Expert opportunity, focused on Parkinson’s disease medication management.
… Full Story>